• Large international study supports new treatment for rare type of stroke
    Large international study supports new treatment for rare type of stroke The DOAC-CVT study, a large international cohort study led by Amsterdam UMC, focuses on the treatment of cerebral venous thrombosis (CVT) using direct oral anticoagulants (DOACs). Last week, the results were revealed during a plenary session at the World Stroke Conference in Abu Dhabi. The data suggest that patients with CVT can be safely and efficaciously treated with direct oral anticoagulants (DOACs). This finding has important implications for patient management. Researcher Jonathan Coutinho tells us more.
  • Meet the speakers of the Amsterdam Neuroscience Annual Meeting 2024
    Meet the speakers of the Amsterdam Neuroscience Annual Meeting 2024 The Amsterdam Neuroscience Annual Meeting 2024 is only weeks away. We have a number of exciting speakers lined up for you – check them out here!
  • Dr. Amélie Fréal receives 850.000 euro Vidi grant
    Dr. Amélie Fréal receives 850.000 euro Vidi grant Dr. Amélie Fréal, assistant professor in the Cellular & Molecular Mechanisms research programme at Amsterdam Neuroscience, has received a Vidi grant of 850.000 euros from the Dutch Research Council (NWO). With this, she will be able to continue her research on understanding the mechanisms controlling the composition of the axon initial segment.

Subscribe to our Newsletter

 Subscribe to our Newsletter